Show simple item record

Evidence for gene–gene epistatic interactions among susceptibility loci for systemic lupus erythematosus

dc.contributor.authorHughes, Travisen_US
dc.contributor.authorAdler, Adamen_US
dc.contributor.authorKelly, Jennifer A.en_US
dc.contributor.authorKaufman, Kenneth M.en_US
dc.contributor.authorWilliams, Adrienne H.en_US
dc.contributor.authorLangefeld, Carl D.en_US
dc.contributor.authorBrown, Elizabeth E.en_US
dc.contributor.authorAlarcón, Graciela S.en_US
dc.contributor.authorKimberly, Robert P.en_US
dc.contributor.authorEdberg, Jeffrey C.en_US
dc.contributor.authorRamsey‐goldman, Rosalinden_US
dc.contributor.authorPetri, Michelle A.en_US
dc.contributor.authorBoackle, Susan A.en_US
dc.contributor.authorStevens, Anne M.en_US
dc.contributor.authorReveille, John D.en_US
dc.contributor.authorSanchez, Elenaen_US
dc.contributor.authorMartín, Javieren_US
dc.contributor.authorNiewold, Timothy B.en_US
dc.contributor.authorVilá, Luis M.en_US
dc.contributor.authorScofield, R. Halen_US
dc.contributor.authorGilkeson, Gary S.en_US
dc.contributor.authorGaffney, Patrick M.en_US
dc.contributor.authorCriswell, Lindsey A.en_US
dc.contributor.authorMoser, Kathy L.en_US
dc.contributor.authorMerrill, Joan T.en_US
dc.contributor.authorJacob, Chaim O.en_US
dc.contributor.authorTsao, Betty P.en_US
dc.contributor.authorJames, Judith A.en_US
dc.contributor.authorVyse, Timothy J.en_US
dc.contributor.authorAlarcón‐riquelme, Marta E.en_US
dc.contributor.authorHarley, John B.en_US
dc.contributor.authorRichardson, Bruce C.en_US
dc.contributor.authorSawalha, Amr H.en_US
dc.date.accessioned2012-03-16T16:00:38Z
dc.date.available2013-04-01T14:17:24Zen_US
dc.date.issued2012-02en_US
dc.identifier.citationHughes, Travis; Adler, Adam; Kelly, Jennifer A.; Kaufman, Kenneth M.; Williams, Adrienne H.; Langefeld, Carl D.; Brown, Elizabeth E.; Alarcón, Graciela S. ; Kimberly, Robert P.; Edberg, Jeffrey C.; Ramsey‐goldman, Rosalind ; Petri, Michelle; Boackle, Susan A.; Stevens, Anne M.; Reveille, John D.; Sanchez, Elena; Martín, Javier ; Niewold, Timothy B.; Vilá, Luis M. ; Scofield, R. Hal; Gilkeson, Gary S.; Gaffney, Patrick M.; Criswell, Lindsey A.; Moser, Kathy L.; Merrill, Joan T.; Jacob, Chaim O.; Tsao, Betty P.; James, Judith A.; Vyse, Timothy J.; Alarcón‐riquelme, Marta E. ; Harley, John B.; Richardson, Bruce C.; Sawalha, Amr H. (2012). "Evidence for geneâ gene epistatic interactions among susceptibility loci for systemic lupus erythematosus." Arthritis & Rheumatism 64(2): 485-492. <http://hdl.handle.net/2027.42/90353>en_US
dc.identifier.issn0004-3591en_US
dc.identifier.issn1529-0131en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90353
dc.description.abstractObjective Several confirmed genetic susceptibility loci for lupus have been described. To date, no clear evidence for genetic epistasis in lupus has been established. The aim of this study was to test for gene–gene interactions in a number of known lupus susceptibility loci. Methods Eighteen single‐nucleotide polymorphisms tagging independent and confirmed lupus susceptibility loci were genotyped in a set of 4,248 patients with lupus and 3,818 normal healthy control subjects of European descent. Epistasis was tested by a 2‐step approach using both parametric and nonparametric methods. The false discovery rate (FDR) method was used to correct for multiple testing. Results We detected and confirmed gene–gene interactions between the HLA region and CTLA4 , IRF5 , and ITGAM and between PDCD1 and IL21 in patients with lupus. The most significant interaction detected by parametric analysis was between rs3131379 in the HLA region and rs231775 in CTLA4 (interaction odds ratio 1.19, Z = 3.95, P = 7.8 × 10 −5 [FDR ≤0.05], P for multifactor dimensionality reduction = 5.9 × 10 −45 ). Importantly, our data suggest that in patients with lupus, the presence of the HLA lupus risk alleles in rs1270942 and rs3131379 increases the odds of also carrying the lupus risk allele in IRF5 (rs2070197) by 17% and 16%, respectively ( P = 0.0028 and P = 0.0047, respectively). Conclusion We provide evidence for gene–gene epistasis in systemic lupus erythematosus. These findings support a role for genetic interaction contributing to the complexity of lupus heritability.en_US
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.titleEvidence for gene–gene epistatic interactions among susceptibility loci for systemic lupus erythematosusen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan and Ann Arbor VA Medical Center, Ann Arboren_US
dc.contributor.affiliationotherUniversity of Puerto Rico, San Juan, Puerto Ricoen_US
dc.contributor.affiliationotherOklahoma Medical Research Foundation, Oklahoma Cityen_US
dc.contributor.affiliationotherOklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, and Oklahoma City VA Medical Center, Oklahoma Cityen_US
dc.contributor.affiliationotherWake Forest University Health Sciences Center, Winston‐Salem, North Carolinaen_US
dc.contributor.affiliationotherUniversity of Alabama at Birminghamen_US
dc.contributor.affiliationotherNorthwestern University Feinberg School of Medicine, Chicago, Illinoisen_US
dc.contributor.affiliationotherJohns Hopkins University School of Medicine, Baltimore, Marylanden_US
dc.contributor.affiliationotherUniversity of Colorado Denver School of Medicine, Auroraen_US
dc.contributor.affiliationotherUniversity of Washington and Seattle Children's Research Institute, Seattleen_US
dc.contributor.affiliationotherUniversity of Texas Health Science Center at Houstonen_US
dc.contributor.affiliationotherInstituto de Parasitología y Biomedicina López‐Neyra, CSIC, Granada, Spainen_US
dc.contributor.affiliationotherUniversity of Chicago, Chicago, Illinoisen_US
dc.contributor.affiliationotherMedical University of South Carolina, Charlestonen_US
dc.contributor.affiliationotherUniversity of California, San Franciscoen_US
dc.contributor.affiliationotherOklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma Cityen_US
dc.contributor.affiliationotherUniversity of Southern California, Los Angelesen_US
dc.contributor.affiliationotherUniversity of California, Los Angelesen_US
dc.contributor.affiliationotherKing's College London and Guy's Hospital, London, UKen_US
dc.contributor.affiliationotherOklahoma Medical Research Foundation, Oklahoma Cityen_US
dc.contributor.affiliationotherCincinnati Children's Hospital Medical Center and Cincinnati VA Medical Center, Cincinnati, Ohioen_US
dc.contributor.affiliationotherCenter for Genomics and Oncological Research Pfizer–University of Granada–Junta de Andalucia, Granada, Spainen_US
dc.contributor.affiliationotherOklahoma Medical Research Foundation, 825 Northeast 13th Street, MS#24, Oklahoma City, OK 73104en_US
dc.identifier.pmid21952918en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90353/1/33354_ftp.pdf
dc.identifier.doi10.1002/art.33354en_US
dc.identifier.sourceArthritis & Rheumatismen_US
dc.identifier.citedreferenceHellquist A, Jarvinen TM, Koskenmies S, Zucchelli M, Orsmark‐Pietras C, Berglind L, et al. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus. J Rheumatol 2009; 36: 1631 – 8.en_US
dc.identifier.citedreferenceFlesher DL, Sun X, Behrens TW, Graham RR, Criswell LA. Recent advances in the genetics of systemic lupus erythematosus. Expert Rev Clin Immunol 2010; 6: 461 – 79.en_US
dc.identifier.citedreferenceGraham DS, Graham RR, Manku H, Wong AK, Whittaker JC, Gaffney PM, et al. Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat Genet 2008; 40: 83 – 9.en_US
dc.identifier.citedreferenceRemmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007; 357: 977 – 86.en_US
dc.identifier.citedreferenceLee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases: a meta‐analysis. Rheumatology (Oxford) 2007; 46: 49 – 56.en_US
dc.identifier.citedreferenceProkunina L, Castillejo‐Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32: 666 – 9.en_US
dc.identifier.citedreferenceLee YH, Witte T, Momot T, Schmidt RE, Kaufman KM, Harley JB, et al. The mannose‐binding lectin gene polymorphisms and systemic lupus erythematosus: two case–control studies and a meta‐analysis. Arthritis Rheum 2005; 52: 3966 – 74.en_US
dc.identifier.citedreferenceNath SK, Han S, Kim‐Howard X, Kelly JA, Viswanathan P, Gilkeson GS, et al. A nonsynonymous functional variant in integrin‐α M (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 2008; 40: 152 – 4.en_US
dc.identifier.citedreferenceVelez DR, White BC, Motsinger AA, Bush WS, Ritchie MD, Williams SM, et al. A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Genet Epidemiol 2007; 31: 306 – 15.en_US
dc.identifier.citedreferenceSawalha AH, Kaufman KM, Kelly JA, Adler AJ, Aberle T, Kilpatrick J, et al. Genetic association of interleukin‐21 polymorphisms with systemic lupus erythematosus. Ann Rheum Dis 2008; 67: 458 – 61.en_US
dc.identifier.citedreferenceMagnusson V, Johanneson B, Lima G, Odeberg J, Alarcon‐Segovia D, Alarcon‐Riquelme ME. Both risk alleles for FcγRIIA and FcγRIIIA are susceptibility factors for SLE: a unifying hypothesis. Genes Immun 2004; 5: 130 – 7.en_US
dc.identifier.citedreferenceBarreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C, et al. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet 2004; 12: 620 – 6.en_US
dc.identifier.citedreferenceHom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, et al. Association of systemic lupus erythematosus with C8orf13‐BLK and ITGAM‐ITGAX. N Engl J Med 2008; 358: 900 – 9.en_US
dc.identifier.citedreferenceKozyrev SV, Abelson AK, Wojcik J, Zaghlool A, Linga Reddy MV, Sanchez E, et al. Functional variants in the B‐cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008; 40: 211 – 6.en_US
dc.identifier.citedreferenceSimpson N, Gatenby PA, Wilson A, Malik S, Fulcher DA, Tangye SG, et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum 2010; 62: 234 – 44.en_US
dc.identifier.citedreferenceGood‐Jacobson KL, Szumilas CG, Chen L, Sharpe AH, Tomayko MM, Shlomchik MJ. PD‐1 regulates germinal center B cell survival and the formation and affinity of long‐lived plasma cells. Nat Immunol 2010; 11: 535 – 42.en_US
dc.identifier.citedreferenceMcHeyzer‐Williams LJ, Pelletier N, Mark L, Fazilleau N, McHeyzer‐Williams MG. Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol 2009; 21: 266 – 73.en_US
dc.identifier.citedreferenceDiPlacido LD, Craft J. Emerging from the shadows: follicular helper T cells in autoimmunity [editorial]. Arthritis Rheum 2010; 62: 6 – 8.en_US
dc.identifier.citedreferenceFagerholm SC, Varis M, Stefanidakis M, Hilden TJ, Gahmberg CG. α‐Chain phosphorylation of the human leukocyte CD11b/CD18 (Mac‐1) integrin is pivotal for integrin activation to bind ICAMs and leukocyte extravasation. Blood 2006; 108: 3379 – 86.en_US
dc.identifier.citedreferenceLi Y, Zhang L. The fourth blade within the β‐propeller is involved specifically in C3bi recognition by integrin α M β 2. J Biol Chem 2003; 278: 34395 – 402.en_US
dc.identifier.citedreferenceJaneway CA, Travers P, Walport M, Shlomchik MJ. T cell‐mediated immunity. In: Immunobiology: the immune system in health and disease. 6th ed. New York: Garland Sciences; 2005. p. 319 – 65.en_US
dc.identifier.citedreferenceCordell HJ. Detecting gene‐gene interactions that underlie human diseases. Nat Rev Genet 2009; 10: 392 – 404.en_US
dc.identifier.citedreferenceYang Q, Khoury MJ, Sun F, Flanders WD. Case‐only design to measure gene‐gene interaction. Epidemiology 1999; 10: 167 – 70.en_US
dc.identifier.citedreferenceLage‐Castellanos A, Martinez‐Montes E, Hernandez‐Cabrera JA, Galan L. False discovery rate and permutation test: an evaluation in ERP data analysis. Stat Med 2010; 29: 63 – 74.en_US
dc.identifier.citedreferenceBenjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289 – 300.en_US
dc.identifier.citedreferenceMoore JH. Detecting, characterizing, and interpreting nonlinear gene‐gene interactions using multifactor dimensionality reduction. Adv Genet 2010; 72: 101 – 16.en_US
dc.identifier.citedreferenceRitchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, et al. Multifactor‐dimensionality reduction reveals high‐order interactions among estrogen‐metabolism genes in sporadic breast cancer. Am J Hum Genet 2001; 69: 138 – 47.en_US
dc.identifier.citedreferencePurcell S, Neale B, Todd‐Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole‐genome association and population‐based linkage analyses. Am J Hum Genet 2007; 81: 559 – 75.en_US
dc.identifier.citedreferenceSanchez E, Webb RD, Rasmussen A, Kelly JA, Riba L, Kaufman KM, et al. Genetically determined Amerindian ancestry correlates with increased frequency of risk alleles for systemic lupus erythematosus. Arthritis Rheum 2010; 62: 3722 – 9.en_US
dc.identifier.citedreferenceKosoy R, Nassir R, Tian C, White PA, Butler LM, Silva G, et al. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat 2009; 30: 69 – 78.en_US
dc.identifier.citedreferenceTian C, Hinds DA, Shigeta R, Adler SG, Lee A, Pahl MV, et al. A genomewide single‐nucleotide‐polymorphism panel for Mexican American admixture mapping. Am J Hum Genet 2007; 80: 1014 – 23.en_US
dc.identifier.citedreferenceYang N, Li H, Criswell LA, Gregersen PK, Alarcon‐Riquelme ME, Kittles R, et al. Examination of ancestry and ethnic affiliation using highly informative diallelic DNA markers: application to diverse and admixed populations and implications for clinical epidemiology and forensic medicine. Hum Genet 2005; 118: 382 – 92.en_US
dc.identifier.citedreferenceHochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.en_US
dc.identifier.citedreferenceTan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271 – 7.en_US
dc.identifier.citedreferenceGraham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, Baechler EC, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 2007; 104: 6758 – 63.en_US
dc.identifier.citedreferenceHarley JB, Alarcon‐Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, et al. Genome‐wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40: 204 – 10.en_US
dc.identifier.citedreferenceSuarez‐Gestal M, Calaza M, Gonzalez A. Lack of interaction between systemic lupus erythematosus‐associated polymorphisms in TYK2 and IRF5. J Rheumatol 2010; 37: 676 – 7.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.